An injectable vitreous substitute with sustained release of metformin for enhanced uveal melanoma immunotherapy

Abstract

Uveal melanoma (UM) is the most prevalent primary intraocular malignant tumor in adults with a high rate of metastasis. Conventional treatments have limited effects on metastasis and cause permanent ocular...